|
| |
Overview
Financial Highlight
HeadlinesBusiness Background Supercomnet Technologies Bhd is principally involved in the manufacturing of Polyvinyl chloride (PVC) compound and cables and wires for electronic devices and data control switches. The firm’s product portfolio comprises automobile plug-in cables, copper and jumper wires, cords and cord sets, LAN cable assemblies, and a full range of computer data cables. The company’s operations are located in Malaysia.
  BobLimm Another good quarter by Scomnet key customers Edwards Lifesciences. Sales grew 21%. https://www.prnewswire.com/news-releases/edwards-lifesciences-reports-third-quarter-results-300944228.html 25/10/2019 6:30 AM Michael Kwok I hope the website target price is right.Please see the reason below; Scomnet Michael Kwok Are u all sure?I may say it may test 70 cent(best case scenario) and 60 cent(worst case scenario).One things investor made mistake If not looking at Monthly chart.3-4 years over bought in Monthly chart.Up already by 20-23 times from Its bottom. 27/10/2019 8:16 PM (https://klse.i3investor.com/blogs/Bursa_Master/232210.jsp) 27/10/2019 8:27 PM BobLimm Fairly accurate assessment by Bursa Master. This is considering that Edwards Lifesciences is their largest customer. I read Scomnet has commercialized other medical business opportunities, these growth should be seen in their forthcoming quarterly report. https://klse.i3investor.com/m/blog/Bursa_Master/232210.jsp 27/10/2019 10:51 PM LiimInvest BobLimm we will huat together & I am fully agreed your comment. TP over 1.20 soon 27/10/2019 11:54 PM BobLimm Let's see Q3 earnings results in November. Additional revenues will be coming out from their new customers. Tax exemption for new products are likely to be reflected in this quarter, that will boost the bottom line. 02/11/2019 4:12 PM aspiral25 Uptrend stock with overbought status. Long term still consider good may hold. Short term go look other stock. Trader just study ta 06/11/2019 12:28 PM BobLimm Another good news from one of their key customers. scomnet. Edward's Lifesciences Sapien 3 TAVI receiving approval for Europe market for low risk patients. Down stream suppliers confirm will benefit from this expanded market. https://markets.businessinsider.com/news/stocks/edwards-sapien-3-tavi-receives-expanded-approval-in-europe-1028662712 06/11/2019 4:33 PM  Huat1 Good profitable company with good track records. Expect the coming QR to be good too. Hold tight 15/11/2019 3:57 PM  Investar2862 Positive news for SCOMNET... https://www.freemalaysiatoday.com/category/nation/2019/11/19/top-british-medtech-firm-to-open-in-penang-employ-800-locals/ 20/11/2019 5:22 AM t_nike2002 Still overpriced... all future profits already built into the current price already....If results not good then it will tumble badly... 26/11/2019 11:31 AM dasm1284 next QR should be good as their major customer Edward Life sciences is doing well. their share price is near record high 27/11/2019 8:13 AM BobLimm For the period under review , Group revenue has been increased by 48.28% (or RM29.49 million) from RM 61.08 million to RM 90.57 million whereby Supercomal Medical Product(SMP) contribute 20.61 million of the sales increment. The profit after tax increased by 40.44 % ( or RM 4.11 million) from RM 10.15 million to RM 14.26 million after the amortisation of RM 3 million intangible assets. The improvement in profit mainly due to contribution from SMP which accounted 80% of profit for the period . Medical business is contributing 2/3 of the revenue growth. 27/11/2019 6:24 PM Excommunicado Being the person who is directly involved in Sapien 3 valve by Edwards Lifesciences , it's the only valve in the world that has direct competition with the valve by medtronic. The Asian penetration of this valve is still at the beginning stage, but soon we will see an increase in the usage of sapien 3. The only downside is the vale costs about 100k. However, it's been widely used in European countries. What I can see is the revenue for it will continue to grow in near future because of the new research paper on the usage of the valve named Partner III trial. Hence, it's quite a safe assumption that the revenue will keep growing from the medical side. 02/12/2019 11:10 PM Investar2862 Congratulation! You got your charting right... Posted by Huat1 > Dec 15, 2019 7:27 PM | Report Abuse Immediate support at 0.72. Already Oversold !!! Time to rebound 18/12/2019 11:06 AM BobLimm Coming up https://www.thestar.com.my/business/business-news/2020/01/04/top-20-stock-picks-for-2020 04/01/2020 4:16 PM  |
|
